Role of disseminated intravascular coagulation in severe sepsis.


Journal

Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 20 01 2019
revised: 23 03 2019
accepted: 23 04 2019
pubmed: 6 5 2019
medline: 3 3 2020
entrez: 5 5 2019
Statut: ppublish

Résumé

Disseminated intravascular coagulation (DIC) associated with multiple organ dysfunction syndrome (MODS) plays pivotal roles in severe sepsis. We performed a multicenter, prospective data collection study and retrospectively analyzed the data to confirm the role of DIC in severe sepsis. Eligible patients were ICU patients who met the definitions of severe sepsis, and 1013 patients were included. DIC scores as well as disease severity and the development of MODS on the day of the diagnosis of severe sepsis (day 0) and at day 3 were evaluated. The primary outcome was hospital mortality, and MODS on days 0 and 3 was the secondary outcomes. The overall mortality rate of severe sepsis was 21.5%, and the prevalence of DIC was 50.9% (516/1013). DIC patients were more seriously ill and exhibited a higher prevalence of MODS (32.0% vs. 13.1%) on day 0 and worse mortality rate (24,8% vs. 17.5%) than non-DIC patients. DIC patients also showed a lower survival probability than non-DIC patients (Log rank p = 0.028). Logistic regression analyses after propensity score adjustment for potential confounders confirmed a significant association between DIC and MODS and hospital death in the patients with severe sepsis. The new development of DIC and persistent DIC from days 0 to 3 were associated with a high incidence of MODS and low survival probability. The mortality rate of severe sepsis has been improved; however, DIC is still associated with the poor prognosis of these patients. Evaluating the dynamic changes in the DIC status may improve the prediction capability.

Sections du résumé

BACKGROUND BACKGROUND
Disseminated intravascular coagulation (DIC) associated with multiple organ dysfunction syndrome (MODS) plays pivotal roles in severe sepsis.
OBJECTIVES OBJECTIVE
We performed a multicenter, prospective data collection study and retrospectively analyzed the data to confirm the role of DIC in severe sepsis.
METHODS METHODS
Eligible patients were ICU patients who met the definitions of severe sepsis, and 1013 patients were included. DIC scores as well as disease severity and the development of MODS on the day of the diagnosis of severe sepsis (day 0) and at day 3 were evaluated. The primary outcome was hospital mortality, and MODS on days 0 and 3 was the secondary outcomes.
RESULTS RESULTS
The overall mortality rate of severe sepsis was 21.5%, and the prevalence of DIC was 50.9% (516/1013). DIC patients were more seriously ill and exhibited a higher prevalence of MODS (32.0% vs. 13.1%) on day 0 and worse mortality rate (24,8% vs. 17.5%) than non-DIC patients. DIC patients also showed a lower survival probability than non-DIC patients (Log rank p = 0.028). Logistic regression analyses after propensity score adjustment for potential confounders confirmed a significant association between DIC and MODS and hospital death in the patients with severe sepsis. The new development of DIC and persistent DIC from days 0 to 3 were associated with a high incidence of MODS and low survival probability.
CONCLUSIONS CONCLUSIONS
The mortality rate of severe sepsis has been improved; however, DIC is still associated with the poor prognosis of these patients. Evaluating the dynamic changes in the DIC status may improve the prediction capability.

Identifiants

pubmed: 31054468
pii: S0049-3848(19)30218-X
doi: 10.1016/j.thromres.2019.04.025
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

182-188

Investigateurs

Osamu Tasaki (O)
Yasumitsu Mizobata (Y)
Hiraku Funakoshi (H)
Toshiro Okuyama (T)
Iwao Yamashita (I)
Toshio Kanai (T)
Yasuo Yamada (Y)
Mayuki Aibiki (M)
Keiji Sato (K)
Susumu Yamashita (S)
Susumu Yamashita (S)
Kenichi Yoshida (K)
Shunji Kasaoka (S)
Akihide Kon (A)
Hiroshi Rinka (H)
Hiroshi Kato (H)
Hiroshi Okudera (H)
Eichi Narimatsu (E)
Toshifumi Fujiwara (T)
Manabu Sugita (M)
Yasuo Shichinohe (Y)
Hajime Nakae (H)
Ryouji Iiduka (R)
Yuji Murata (Y)
Mitsunobu Nakamura (M)
Yoshitake Sato (Y)
Hiroyasu Ishikura (H)
Yasuhiro Myojo (Y)
Yasuyuki Tsujita (Y)
Kosaku Kinoshita (K)
Hiroyuki Yamaguchi (H)
Toshihiro Sakurai (T)
Satoru Miyatake (S)
Takao Saotome (T)
Susumu Yasuda (S)
Toshikazu Abe (T)
Hiroshi Ogura (H)
Yutaka Umemura (Y)
Atsushi Shiraishi (A)
Shigeki Kushimoto (S)
Daizoh Saitoh (D)
Seitaro Fujishima (S)
Junichi Sasaki (J)
Toshihiko Mayumi (T)
Yasukazu Shiino (Y)
Taka-Aki Nakada (TA)
Takehiko Tarui (T)
Toru Hifumi (T)
Yasuhiro Otomo (Y)
Joji Kotani (J)
Yuichiro Sakamoto (Y)
Shin-Ichiro Shiraishi (SI)
Kiyotsugu Takuma (K)
Ryosuke Tsuruta (R)
Akiyoshi Hagiwara (A)
Kazuma Yamakawa (K)
Naoshi Takeyama (N)
Norio Yamashita (N)
Hiroto Ikeda (H)
Yasuaki Mizushima (Y)
Satoshi Gando (S)

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Satoshi Gando (S)

Department of Anesthesiology and Critical Medicine, Hokkaido University Graduate School of Medicine, Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Japan. Electronic address: gandoicoud@icloud.com.

Atsushi Shiraishi (A)

Emergency and Trauma Center, Kameda Medical Center, Japan.

Kazuma Yamakawa (K)

Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Japan.

Hiroshi Ogura (H)

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Japan.

Daizoh Saitoh (D)

Division of Traumatology, Research Institute, National Defense Medical College, Japan.

Seitaro Fujishima (S)

Center for General Medicine Education, Keio University School of Medicine, Japan.

Toshihiko Mayumi (T)

Department of Emergency Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Shigeki Kushimoto (S)

Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Japan.

Toshikazu Abe (T)

Department of General Medicine, Juntendo University, Health Services Research and Development Center, University of Tsukuba, Japan.

Yasukazu Shiino (Y)

Department of Acute Medicine, Kawasaki Medical School, Japan.

Taka-Aki Nakada (TA)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Japan.

Takehiko Tarui (T)

Department of Trauma and Critical Care Medicine, Kyorin University School of Medicine, Japan.

Toru Hifumi (T)

Department of Emergency and Critical Care Medicine, St. Luke's International Hospital, Japan.

Yasuhiro Otomo (Y)

Trauma and Acute Critical Care Center, Medical Hospital, Tokyo Medical and Dental University, Japan.

Kohji Okamoto (K)

Department of Surgery, Center for Gastroenterology and Liver Disease, Kitakyushu City Yahata Hospital, Japan.

Yutaka Umemura (Y)

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Japan.

Joji Kotani (J)

Division of Disaster and Emergency Medicine, Department of Surgery Related, Kobe University Graduate School of Medicine, Japan.

Yuichiro Sakamoto (Y)

Emergency and Critical Care Medicine, Saga University Hospital, Japan.

Junichi Sasaki (J)

Department of Emergency and Critical Care Medicine, Keio University School of Medicine, Japan.

Shin-Ichiro Shiraishi (SI)

Department of Emergency and Critical Care Medicine, Aizu Chuo Hospital, Japan.

Kiyotsugu Takuma (K)

Emergency & Critical Care Center, Kawasaki Municipal Kawasaki Hospital, Japan.

Ryosuke Tsuruta (R)

Advanced Medical Emergency & Critical Care Center, Yamaguchi University Hospital, Japan.

Akiyoshi Hagiwara (A)

Center Hospital of the National Center for Global Health and Medicine, Japan.

Tomohiko Masuno (T)

Department of Emergency and Critical Care Medicine, Nippon Medical School, Japan.

Naoshi Takeyama (N)

Advanced Critical Care Center, Aichi Medical University Hospital, Japan.

Norio Yamashita (N)

Advanced Emergency Medical Service Center Kurume University Hospital, Japan.

Hiroto Ikeda (H)

Department of Emergency Medicine, Teikyo University School of Medicine, Japan.

Masashi Ueyama (M)

Department of Trauma, Critical Care Medicine, and Burn Center, Japan Community Healthcare Organization, Chukyo Hospital, Japan.

Satoshi Fujimi (S)

Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH